Cytrellis Biosystems, a leader in medical aesthetics focused on skin restoration, has announced the launch of ellacor® at Lawrence Park Plastic Surgery, marking the first time the innovative Micro-Coring™ Technology is available in a Canadian plastic surgery office. Under the leadership of Dr. Mathew Plant, MD FRCSC, the practice now offers patients in Toronto a minimally invasive option to remove excess skin without traditional surgery.
ellacor® works by precisely removing excess skin at a micro-scale, resulting in visible tightening while avoiding the risks and downtime associated with surgical procedures. The technology complements Dr. Plant’s evidence-based approach to aesthetic medicine, which emphasizes measurable outcomes, patient education, and tailored treatment plans.
“Everything we offer at our practice must be grounded in science and deliver outcomes I can confidently stand behind,” said Dr. Plant. “ellacor represents a fundamentally different way of addressing excess skin, applying surgical principles with microscale precision. It gives patients a meaningful option between non-invasive treatments and surgery, allowing me to deliver results aligned with my philosophy of intentional, evidence-based aesthetic care.”
Dr. Plant’s practice is recognized for blending surgical expertise with a boutique patient experience, ensuring each individual receives personalized guidance from consultation through recovery. The team prioritizes transparency, patient education, and creating an environment where clients feel informed and supported throughout their treatment journey.
“We’re proud to partner with Dr. Plant as the first Toronto plastic surgeon to offer ellacor,” said Denise Dajles, CEO of Cytrellis Biosystems. “His commitment to precision, evidence-based medicine, and patient-centered care reflects the kind of clinical leadership that drives meaningful innovation. Physicians who focus on both outcomes and education are key to helping patients understand the benefits this technology provides.”
With the launch of ellacor®, Lawrence Park Plastic Surgery strengthens its reputation for delivering advanced aesthetic solutions while expanding non-surgical treatment options for Canadian patients. Consultations for the procedure are now available at the Toronto-based practice.
About Dr. Mathew Plant, MD, FRCSC
Dr. Mathew Plant is a board-certified plastic surgeon in Toronto known for his precision-driven, evidence-based approach to aesthetic and reconstructive surgery. His practice emphasizes individualized care, patient education, and a boutique clinical experience, supporting patients from consultation through recovery. Dr. Plant and his team focus on achieving natural, confidence-boosting results while continually refining techniques and technologies.
About Cytrellis Biosystems
Cytrellis Biosystems is a medical aesthetics company advancing skin restoration through evidence-based innovations. Its flagship product, ellacor®, uses Micro-Coring™ Technology, the only FDA-cleared non-surgical treatment to remove excess skin and address moderate to severe wrinkles. The company focuses on consistent results and exceeding patient expectations.
